Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
363M
-
Number of holders
-
81
-
Total 13F shares, excl. options
-
119M
-
Shares change
-
-1.2M
-
Total reported value, excl. options
-
$221M
-
Value change
-
-$2.4M
-
Put/Call ratio
-
0.47
-
Number of buys
-
32
-
Number of sells
-
-45
-
Price
-
$1.86
Significant Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2022
101 filings reported holding LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2022.
LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) has 81 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 119M shares
of 363M outstanding shares and own 32.7% of the company stock.
Largest 10 shareholders include Artal Group S.A. (71.2M shares), BVF INC/IL (14.1M shares), FMR LLC (5.29M shares), BlackRock Inc. (4.52M shares), VANGUARD GROUP INC (3.92M shares), D. E. Shaw & Co., Inc. (3.23M shares), NEA Management Company, LLC (2.38M shares), PINNACLE ASSOCIATES LTD (2.09M shares), STATE STREET CORP (1.35M shares), and GEODE CAPITAL MANAGEMENT, LLC (1.34M shares).
This table shows the top 81 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.